JAK-IN-32
JAK-IN-32 (XC) is a bi-aryl meta-pyrimidine inhibitor of JAK kinase[1].
Product Specifications
CAS Number
936091-56-4
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/jak-in-32.html
Solubility
10 mM in DMSO
Smiles
CC(C)(NS(C1=CC=CC(NC2=NC(NC3=CC(CN4CCOCC4)=CC=C3)=NC=C2C)=C1)(=O)=O)C
Molecular Formula
C26H34N6O3S
Molecular Weight
510.65
References & Citations
[1]Glenn Noronha, et al. Bi-aryl meta-pyrimidine inhibitors of kinases. Patent. US20110212077A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040956-100 1x 100 µL
UACA / Nucling (AE-5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
